Dr. Andrew Thomas Tkaczuk, MD

Dr. Tkaczuk practices at Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University.

Dr. Tkaczuk's NPI, 1154663748, was assigned on March 21, 2013. Dr. Tkaczuk graduated from University of Maryland School of Medicine in 2013. Dr. Tkaczuk holds Georgia license 79944.

Dr. Tkaczuk's primary practice is Emory University Hospital Midtown, at 550 Peachtree Street, NE, Atlanta, GA 30308 in Fulton County. The practice phone is (404) 686-2450.

Dr. Tkaczuk's primary practice is Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University. Dr. Tkaczuk is also affiliated with Piedmont Augusta. The medical group on file is Emory Clinic. Dmand AI also links Dr. Tkaczuk to 2 more hospitals, 2 medical groups, 1 clinical lab and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tkaczuk practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Tkaczuk's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Tkaczuk is licensed in Georgia.

CMS data shows 724 Medicare services from Dr. Tkaczuk across 13 procedure codes in 2024, for 299 Medicare patients. Medicare paid $64,793 for them.

CMS counts 299 Medicare patients who saw Dr. Tkaczuk in 2024. The largest group is 65 to 74, with 141 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tkaczuk's median patient age at 67, with 62% women.

In 2024, Dr. Tkaczuk wrote 90 Medicare Part D claims for 45 patients. 87% of them were for generic drugs. CMS names the drug for 42 of them, across 3 drugs with 11 or more claims each, at $750 in total drug cost. In 2023, CMS named 66 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Tkaczuk for performance year 2024, reported through an alternative payment model (APM). Dr. Tkaczuk accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Tkaczuk, published from 2018 to 2025. 2023 was the busiest year, with 3. The most frequent topics are Bevacizumab, Papillomavirus Infections and Respiratory Tract Infections. Dr. Tkaczuk has published most often in Laryngoscope. Dr. Tkaczuk's most frequent co-authors are Adam M. Klein, MD, Conor Ernst Steuer, MD and Nicole C. Schmitt, MD.

CMS Open Payments shows 7 general payments to Dr. Tkaczuk from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Fisher & Paykel Healthcare Inc paid the most, $142.

Dr. Tkaczuk graduated from University of Maryland School of Medicine in 2013.